questionText: To ask the Secretary of State for Health and Social Care, if he will make an assessment of the (a) potential implications for his policies of the proportion of individual funding request applications for chemosat treatment that are rejected and (b) adequacy of support provided to rare cancer patients.
answerText: The National Institute for Health and Care Excellence (NICE) published guidance in 2021, through its interventional procedures programme, that recommends that chemosaturation can be used for patients with secondary liver metastases resulting from a primar...
heading: Rare Cancers: Medical Treatments